Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
49.42
-0.67 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
48.69
-1.48%
After-hours: Aug 15, 2025, 07:10 PM EDT
Akero Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -283.96M | -269.44M | -252.06M | -237.22M | -204.18M | -179.27M | -151.76M | -119.63M | -115.52M | -111.83M | -112.03M | -121.4M | -110.19M | -111.72M | -100.78M | -98.06M | -95.14M | -82.41M |
Depreciation & Amortization | -15.05M | -12.37M | -10.09M | -10.1M | 9K | 19K | 29K | 37K | 43K | 43K | 43K | 44K | 42K | 41K | 41K | 41K | 38K | 28K |
Stock-Based Compensation | 32.48M | 31.08M | 29.7M | 28.64M | 26.91M | 24.05M | 21.5M | 19.42M | 25.41M | 24.78M | 23.24M | 21.84M | 12.73M | 11M | 10.05M | 9.33M | 8.26M | 7.15M |
Other Working Capital | 5.83M | -15.43M | -3.4M | -9.96M | -7.25M | 3.01M | -2.98M | -19.53M | -5.64M | -6.7M | -5.43M | 5.71M | 8.04M | 15.33M | 6.45M | 9.14M | 11.15M | -6.17M |
Other Non-Cash Items | 8.61M | 6.17M | 3.73M | -1.6M | -12.53M | -10.12M | -8.46M | -49K | -33K | -133K | 658K | 492K | 352K | 332K | 203K | 200K | 216K | 260K |
Deferred Income Tax | n/a | n/a | n/a | 4.71M | 1.44M | n/a | n/a | -4.71M | -1.44M | n/a | n/a | 479K | 768K | 950K | 1.07M | 716K | 427K | 245K |
Change in Working Capital | 4.49M | -18.07M | -1.39M | 3.93M | -2.59M | 9.45M | -6.67M | -17.32M | -5.62M | -7.16M | -4.46M | 4.8M | 12.58M | 15.18M | 9.73M | 11.4M | 10.92M | -3.1M |
Operating Cash Flow | -253.42M | -262.63M | -230.11M | -211.64M | -190.94M | -155.88M | -145.37M | -122.25M | -97.15M | -94.27M | -92.52M | -93.7M | -83.69M | -84.21M | -79.68M | -76.38M | -75.28M | -77.83M |
Capital Expenditures | n/a | -999K | -999K | -999K | -999K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -148K | -148K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -143K | -143K | -143K |
Purchase of Investments | -796.64M | -1.06B | -516.04M | -494.53M | -597.79M | -447.19M | -433.12M | -476.36M | -315.16M | -126.36M | -101.45M | n/a | -11.91M | -43.56M | -43.56M | -52.56M | -121.91M | -90.26M |
Sales Maturities Of Investments | 482.13M | 411.63M | 407.33M | 383.33M | 287.83M | 263.82M | 209.5M | 138.5M | 106M | 57.37M | 37.62M | 49.62M | 80.46M | 89.59M | 85.84M | 100.74M | 88.46M | 105.92M |
Other Investing Acitivies | n/a | -999K | -999K | -999K | -999K | -128.3K | -110.71K | -212.16K | -209.16K | 11.79M | 34.52M | 46.62M | 68.55M | 46.03M | 42.28M | 30.42M | 8.35M | 57.47M |
Investing Cash Flow | -314.5M | -649.74M | -109.71M | -112.19M | -310.96M | -183.36M | -223.62M | -337.85M | -209.16M | -68.98M | -63.83M | 49.62M | 68.55M | 46.03M | 42.28M | 48.18M | -33.6M | 15.52M |
Debt Repayment | -10M | -10M | n/a | 10M | 10M | 10M | 15M | 15M | 15M | 25M | 10M | 10M | 10M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 280K | 280K | 280K | 280K | 373K | 373K | 373K | 373K | 198K | 198K | 198K |
Dividend Paid | n/a | n/a | n/a | -336.86M | -336.86M | -336.86M | -336.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 441.43M | 441.43M | 442.93M | 338.35M | 338.35M | 339.78M | 338.43M | 4.3M | 6M | 29.45M | 29.43M | 26.95M | 25.32M | 710K | 602K | 418K | 579K | 413K |
Financial Cash Flow | 478.02M | 474.44M | 445.85M | 370.36M | 368.1M | 705.1M | 353.32M | 355.54M | 572.63M | 270.65M | 255.63M | 253.15M | 35.32M | 710K | 602K | 418K | 203.13M | 202.97M |
Net Cash Flow | -89.91M | -437.93M | 106.03M | 46.52M | -133.8M | 365.86M | -15.67M | -104.56M | 266.32M | 107.39M | 99.29M | 209.07M | 20.19M | -37.47M | -36.8M | -27.78M | 94.25M | 140.65M |
Free Cash Flow | -253.42M | -263.63M | -231.11M | -212.64M | -191.94M | -155.88M | -145.37M | -122.25M | -97.15M | -94.27M | -92.52M | -93.7M | -83.69M | -84.21M | -79.68M | -76.39M | -75.43M | -77.98M |